Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros

Base de dados
Tipo de documento
Intervalo de ano de publicação
1.
Int J Pharm ; 314(2): 127-36, 2006 May 18.
Artigo em Inglês | MEDLINE | ID: mdl-16490330

RESUMO

The aim of this study was to prepare different types of paclitaxel-loaded, PLGA-based microparticles and lipidic implants, which can directly be injected into the brain tissue. Releasing the drug in a time-controlled manner over several weeks, these systems are intended to optimize the treatment of brain tumors. The latter is particularly difficult because of the blood-brain barrier (BBB), hindering most drugs to reach the target tissue upon systemic administration. Especially paclitaxel (being effective for the treatment of ovarian, breast, lung and other cancers) is not able to cross the BBB to a notable extent since it is a substrate of the efflux transporter P-glycoprotein. Both, biodegradable microparticles as well as small, cylindrical, glycerol tripalmitate-based implants (which can be injected using standard needles) were prepared with different paclitaxel loadings. The effects of several formulation and processing parameters on the resulting drug release kinetics were investigated in phosphate buffer pH 7.4 as well as in a diethylnicotinamide (DENA)/phosphate buffer mixture. Using DSC, SEM, SEC and optical microscopy deeper insight into the underlying drug release mechanisms could be gained. The presence of DENA in the release medium significantly increased the solubility of paclitaxel, accelerated PLGA degradation, increased the mobility of the polymer and drug molecules and fundamentally altered the geometry of the systems, resulting in increased paclitaxel release rates.


Assuntos
Antineoplásicos Fitogênicos/química , Neoplasias Encefálicas/tratamento farmacológico , Portadores de Fármacos , Implantes de Medicamento , Paclitaxel/química , Antineoplásicos Fitogênicos/uso terapêutico , Composição de Medicamentos , Cinética , Ácido Láctico/química , Microesferas , Niquetamida/química , Paclitaxel/uso terapêutico , Ácido Poliglicólico/química , Copolímero de Ácido Poliláctico e Ácido Poliglicólico , Polímeros/química , Solubilidade , Tecnologia Farmacêutica , Triglicerídeos/química
2.
J Control Release ; 93(2): 121-7, 2003 Dec 05.
Artigo em Inglês | MEDLINE | ID: mdl-14636718

RESUMO

New methods and pharmaceutical compositions were developed to increase the aqueous solubility of paclitaxel (PTX), a poorly water-soluble drug. Graft and star-shaped graft polymers consisting of poly(ethylene glycol) (PEG400) graft chains increased the PTX solubility in water by three orders of magnitude. Polyglycerol dendrimers (dendriPGs) dissolved in water at high concentrations without significantly increasing the viscosity and, at 80 wt.%, were found to increase the solubility of PTX 10,000-fold. The solubilized PTX was released from graft polymers, star-shaped graft polymers, and the dendriPGs into the surrounding aqueous solution. The release rate was a function of the star shape and the dendrimer generation. The availability of the new graft, star and dendritic polymers having ethylene glycol units should permit development of novel delivery systems for other poorly water-soluble drugs.


Assuntos
Preparações de Ação Retardada/farmacocinética , Etilenoglicol/farmacocinética , Estrutura Molecular , Paclitaxel/farmacocinética , Polímeros/farmacocinética , Solubilidade/efeitos dos fármacos , Animais , Bovinos , Portadores de Fármacos/farmacocinética , Etilenoglicol/química , Sangue Fetal , Glicerol/análogos & derivados , Glicerol/química , Peso Molecular , Niquetamida/química , Niquetamida/farmacocinética , Paclitaxel/sangue , Paclitaxel/química , Polietilenoglicóis/química , Polietilenoglicóis/metabolismo , Polímeros/química , Relação Quantitativa Estrutura-Atividade , Fatores de Tempo , Viscosidade/efeitos dos fármacos , Água/química
3.
Chem Pharm Bull (Tokyo) ; 46(1): 125-30, 1998 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-9468644

RESUMO

Nicotinamide is a hydrotropic agent that has been demonstrated to solubilize a wide variety of drugs through complexation. Past investigations on the potential interaction of nicotinamide with a solubilized drug have inadequately focused on aliphatic hydrotropes. This study examined the mechanism for the hydrotropic solubilization of nifedipine, a poorly water-soluble drug, in the aqueous solution of nicotinamide using not only nicotinamide analogues but also urea analogues as aliphatic hydrotropes. The values of stability constants, K1:2, at different temperatures in nicotinamide solution were determined by the phase solubility technique, and were utilized to estimate the thermodynamic parameters of complex formation between nifedipine and nicotinamide. The enthalpy change values suggested the participation of intermolecular forces other than hydrogen bonding in complexion. The aqueous solubility of nifedipine was measured in the presence of nicotinamide, urea and their analogues: N-methylnicotinamide, N,N-diethylnicotinamide, nipecotamide, methylurea, ethylurea and butylurea. The drug solubility increased in proportion to the amount of alkyl substituent on the amide nitrogen, and the solubilizing effect of butylurea was as high as that of nicotinamide. Furthermore, the relationship between the logarithmic drug solubilities in 1.0 M aqueous solutions of nicotinamide or urea analogues versus the logarithmic octanol-water partition coefficient values of ligands as an indication of hydrophobicity was found to be linear. The significant contributor to the hydrotropic solubilization of nifedipine with nicotinamide was therefore the ligand hydrophobicity rather than the aromaticity of the pyridine ring.


Assuntos
Niacinamida/química , Nifedipino/química , Estabilidade de Medicamentos , Niacinamida/análogos & derivados , Niquetamida/química , Ácidos Nipecóticos/química , Solubilidade , Temperatura , Termodinâmica , Ureia/análogos & derivados , Ureia/química
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA